[28-20-pm] Pharmacotherapy (Oncology, Personalized, and Others)

3:24 PM - 3:36 PM JST(6:24 AM - 6:36 AM UTC)

[28-20-pm11] Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients.

○Yuko Kanbayashi¹, Eren Tsuchiya², Tadashi Shimizu ³, Mayako Uchida⁴ (1. Osaka Med. Pharm. Univ., 2. Doshisha Women’s Coll. Liberal Arts, 3. Sch. Pharm., Hyogo Med. Univ., 4. Dept. Pharm., Kyushu Univ. Hosp.)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.